Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05673408 · ClinicalTrials.gov registry record
NIBP Validation Study
A clinical trial of Critical Illness, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 189
- Enrollment target
- 5
- Study locations
NCT05673408: Recruiting study of Critical Illness, sponsored by Philips Clinical & Medical Affairs Global.
NCT05673408 is a study of Critical Illness that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 189 participants, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05673408, a study of Critical Illness, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 189 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in critical care patients.
Primary Outcome
The primary endpoint is the accuracy and precision of systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) measured by the Philips NIBP system (including NIBP cuff and portable patient monitor) in comparison to radial arterial line.
Conditions Studied
Interventions
- DEVICE Philips IntelliVue X3 Patient Monitor
Study Locations (5)
Florida
- Mayo Clinic Jacksonville - Jacksonville
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Oregon
- Oregon Health & Science University - Portland
Texas
- University Health Women's and Children's Hospital - San Antonio
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2023-06-23 |
| Est. Completion | 2026-12-31 |
What NCT05673408 shows while recruiting
NCT05673408 is an observational study that tracks outcomes without assigning an intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, below the 3,136-participant average among 91 other Critical Illness trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which Philips IntelliVue X3 Patient Monitor is the first listed.
NCT05673408 lists 5 locations in 5 states (Florida, North Carolina, Oregon).
Frequently Asked Questions
What is clinical trial NCT05673408 about?
NCT05673408 is a clinical study titled "NIBP Validation Study". The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in c...
What is the current status of trial NCT05673408?
This trial is currently recruiting. The enrollment target is 189 participants. The study started on 2023-06-23. Estimated completion is 2026-12-31.
What conditions does trial NCT05673408 study?
This clinical trial studies the following conditions: Critical Illness.
What interventions are being tested in trial NCT05673408?
The interventions under investigation include: Philips IntelliVue X3 Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT05673408?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05673408 being conducted?
This trial has 5 study locations across Florida, North Carolina, Oregon, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05673408's enrollment target sits among peer trials
189 51st of 91 higher than 41 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
RECRUITING · Phase 1
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
- NCT06567795 · 189 participants
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI